Gene Therapy

University Hospitals Selected as Study Site for the Black and African American Connections to Parkinson’s Disease (BLAAC PD) Study

BLAAC PD is an initiative of GP2 in a dedicated effort to better understand the genetic basis of Parkinson’s disease (PD) among underrepresented populations by genotyping more than 150,000 individuals from around the world.

2/1/2024 By Ansley Kelm

AlveoGene Launches to Develop Unique Inhaled Gene Therapies for Rare Respiratory Disorders

UH Harrington Discovery Institute included in partnership to create and fund new gene therapy company focused on inhaled gene therapy to treat rare respiratory diseases.

9/14/2023 By UH Media Relations

UH Cleveland Medical Center Enrolls First Patient at the Site for an AAV Gene Therapy Trial Treating OTC Deficiency

Groundbreaking treatment could ultimately lead OTC deficient patients to a normal lifestyle after years of medications, dietary protein restriction and recurrent hospitalizations.

10/7/2020 By UH Media Relations

Scientists Successfully Test New Way to Deliver Gene Therapy

Researchers use lipids to safely deliver gene therapy to the eye, successfully holding off advance of rare, inherited eye disorder.

2/27/2020 By Ansley Kelm

Cleveland Researchers Test Novel Gene Therapy for Glioblastoma

Promising results that led to new $2.7 million NCI grant to be presented at ASCO annual meeting on June 2.

6/2/2019 By CJ Sheppard